Maze Therapeutics President, R&D and CMO Harold Bernstein disposes of USD 445,522 common shares - MAZE News | RalliesMaze Therapeutics President, R&D and CMO Harold Bernstein disposes of USD 445,522 common shares
M
MAZE• Insider sale and option exercise
- Maze Therapeutics President, R&D and CMO Harold Bernstein sold 16,142 common shares on Aug. 13 at USD 27.61.
- The sale followed the exercise of stock options for 16,142 shares at USD 10.42.
- Bernstein’s directly held common stock position fell to zero following the transactions.
KTB
•
